Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
38 results
D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab
D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab
D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis
D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic
D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates
D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results
D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years
D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center
D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria
D2.194 - Persisten severe cow's milk allergy with successful oral immunotherapy in adulthood
D2.195 - Clinical characteristics of eosinophilic esophagitis and gastroenteritis in Korean children: a single-center study
D2.196 - Utilization of Injectable Epinephrine Among Children with Parent-Reported Food Allergies
D2.197 - Maternal Awareness of the Timing of Allergenic Food Introduction in Early Childhood: A Cross-Sectional Study
D2.198 - Cross-reactivity between Fusarium venenatum and cooked mushrooms and Aspergillus fumigatus: A case study of food-induced allergy
D2.199 - ‘When I became older, I started having to manage that more myself’ – experiences of adolescents with food allergies: a qualitative study
D2.202 - Threshold of Allergic Reactions to Cashew and Pistachio in a Large Israeli Population
D2.203 - Awareness of and adherence to advice on early introduction of food allergens: is it preventing food allergy? Protocol for EarLY Food Allergens iNTroduction (ELYFANT) study
D2.204 - Research priorities for food allergy in children: A James Lind Alliance priority setting partnership
D2.205 - Validation of an Adapted Treatment Burden Questionnaire for Paediatric IgE-Mediated Milk and Egg Allergies: A Multicentre Study
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download